Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) FCF Margin (2016 - 2026)

Angiodynamics' FCF Margin history spans 17 years, with the latest figure at 4.59% for Q1 2026.

  • For Q1 2026, FCF Margin rose 1536.0% year-over-year to 4.59%; the TTM value through Feb 2026 reached 0.37%, up 986.0%, while the annual FY2025 figure was 4.99%, 510.0% up from the prior year.
  • FCF Margin reached 4.59% in Q1 2026 per ANGO's latest filing, down from 4.25% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 22.5% in Q2 2025 to a low of 33.89% in Q3 2023.
  • Average FCF Margin over 5 years is 5.36%, with a median of 0.14% recorded in 2023.
  • Peak YoY movement for FCF Margin: tumbled -2018bps in 2022, then skyrocketed 1536bps in 2026.
  • A 5-year view of FCF Margin shows it stood at 7.36% in 2022, then plummeted by -31bps to 5.09% in 2023, then plummeted by -65bps to 1.8% in 2024, then surged by 136bps to 4.25% in 2025, then crashed by -208bps to 4.59% in 2026.
  • Per Business Quant, the three most recent readings for ANGO's FCF Margin are 4.59% (Q1 2026), 4.25% (Q4 2025), and 21.98% (Q3 2025).